title: Morphological and biochemical features of a medroxyprogesterone acetate (MPA)-resistant MCF-7 breast cancer cell line.
abstract: An MCF-7 human breast cancer line variant (MCF-7/MPA), resistant to medroxyprogesterone-acetate (MPA), was obtained by continuous exposure in vitro to the drug. MCF-7/MPA cells were grown in the presence of 12.5 x 10(-6) M MPA and were selected by increasing the concentration of the drug in the growth medium in a stepwise manner from 0.025 x 10(-6) M up to 12.5 x 10(-6) M. Comparative studies of cellular morphology, cytosolic steroid receptor content and P-Glycoprotein expression were performed on both MCF-7 parental line and MCF-7/MPA variant. MCF-7/MPA cells, when compared to the parental line, exhibit a different morphology in terms of membrane alterations, reduced content of cytosolic progesterone receptor, increased expression of P-glycoprotein along with reduction of Doxorubicin (Dx) activity on the growth of MCF-7/MPA resistant cells.
authors.affiliation: Divisione di Oncologia Medica, Fondazione Clinica de Lavoro, IRCCS, Pavia, Italy.
authors.forename: N
authors.initials: N
authors.lastname: Gibelli
authors.forename: C
authors.initials: C
authors.lastname: Zibera
authors.forename: G
authors.initials: G
authors.lastname: Sica
authors.forename: M
authors.initials: M
authors.lastname: Carbone
authors.forename: P
authors.initials: P
authors.lastname: Pedrazzoli
authors.forename: G
authors.initials: G
authors.lastname: Robustelli della Cuna
mesh_terms: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology* / Q000648:ultrastructure; D002352:Carrier Proteins / Q000502:physiology; D002455:Cell Division / Q000187:drug effects; D004351:Drug Resistance; D004354:Drug Screening Assays, Antitumor; D005434:Flow Cytometry; D006801:Humans; D017258:Medroxyprogesterone Acetate / Q000494:pharmacology*; D008562:Membrane Glycoproteins / Q000502:physiology; D008855:Microscopy, Electron, Scanning; D009376:Neoplasms, Hormone-Dependent / Q000188:drug therapy* / Q000473:pathology* / Q000648:ultrastructure; D011960:Receptors, Estrogen / Q000032:analysis; D011980:Receptors, Progesterone / Q000032:analysis; D014407:Tumor Cells, Cultured / Q000187:drug effects
chemical_list: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D002352:Carrier Proteins; D008562:Membrane Glycoproteins; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; D017258:Medroxyprogesterone Acetate